TELCON RF PHARMACEUTICAL. Inc. (200230.KQ)
KOSDAQ · KRW · Healthcare · Drug Manufacturers - Specialty & Generic
₩2,150 (+4.12%) as of
Key statistics
- Market cap
- 15.35B
- Dividend yield
- 0.00%
- 52-week range
- 1,700.00 – 13,210.00
- Beta
- 0.38
- Revenue (TTM)
- 61.78B
- Profit margin
- -28.29%
- Volume
- 28.82k
About TELCON RF PHARMACEUTICAL. Inc.
TELCON RF PHARMACEUTICAL. Inc. primarily engages in the development, production, and sale of RF coaxial connectors worldwide. It also provides coaxial couplers, distributors, and arresters, as well as cable assemblies; and pharmaceuticals. The company was formerly known as Telcon Co., Ltd. TELCON RF PHARMACEUTICAL. Inc. was founded in 1999 and is headquartered in Yongin-si, South Korea.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Yongin-si, South Korea
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.